Home › Funds › Genus Capital Management Inc. › BMY

Genus Capital Management Inc. position in BMY

BRISTOL-MYERS SQUIBB CO · Health Care

Genus Capital Management Inc. reported holding 134,936 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 0.84% of its reported portfolio and ranking #34 among its reported holdings. Genus Capital Management Inc. has disclosed BMY holdings in 3 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)134.94K sh
Reported value held$8.42M
Portfolio Weight0.84%
First reportedQ4 2024
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Genus Capital Management Inc.'s BMY position evolved

Genus Capital Management Inc. first disclosed a stake in BMY in Q4 2024 at 28,830 shares (US$1.6M). The position peaked in Q3 2026 at 134,936 shares, worth US$8.4M. Across 3 filings, Genus Capital Management Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 134,936 shares valued at US$8.4M. Notable position changes include a 31% trim in Q1 2025 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 28.83K $1.63M New
Q1 2025 19.99K $1.22M Reduce
Q3 2026 134.94K $8.42M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMY and 13F data

BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 26 other funds we track also report a position in BMY — the largest reported positions include Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMY

All BMY fund holders →

FAQ

How long has Genus Capital Management Inc. held BMY?

Genus Capital Management Inc. has disclosed BMY holdings in 3 of the last 8 reported quarters, going back to Q4 2024.

What is Genus Capital Management Inc.'s current position in BMY?

As of Q3 2026, Genus Capital Management Inc. holds 134.94K shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $8.42M, representing 0.84% of its reported portfolio and ranking #34.

Has Genus Capital Management Inc. been buying or selling BMY?

In the latest 13F filing (Q3 2026), Genus Capital Management Inc. newly opened its position in BMY. The position peaked in Q3 2026 at 134.94K shares.

Which other funds hold BMY?

Other major institutional holders of BMY include Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, AQR Capital Management, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.